References
- Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: A systematic review and meta-analysis. Lancet Global Health. 2017;5(9):e888–e97. doi:10.1016/S2214-109X(17)30293-0.
- Nations U. World Population Prospects. 2017. https://www.un.org/development/desa/en/news/population/world-population-prospects-2017.html. Accessed December 14, 2017.
- Fricke TR, Tahhan N, Resnikoff S, et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: Systematic review, meta-analysis, and modelling. Ophthalmology. 2018;125(10):1492–1499. doi:10.1016/j.ophtha.2018.04.013.
- Freeman EE, Egleston BL, West SK, Bandeen-Roche K, Rubin G. Visual acuity change and mortality in older adults. Invest Ophthalmol Vis Sci. 2005;46(11):4040–4045. doi:10.1167/iovs.05-0687.
- Teulings C, Baldwin R. 2014. Secular stagnation: Facts, causes and cures | VOX, CEPR’s policy portal. CEPR. http://voxeu.org/content/secular-stagnation-facts-causes-and-cures.
- Gordon KD, Cruess AF, Bellan L, Mitchell S, Pezzullo ML. The cost of vision loss in Canada. 1. Methodology. Can J Ophthalmol. 2011;46(4):310–314. doi:10.1016/j.jcjo.2011.07.001.
- Economics A. The Global Economic Cost of Visual Impairment. 2010. http://www.icoph.org/dynamic/attachments/resources/globalcostofvi_finalreport.pdfAccess. Economics Pty Limited ABN 82 113 621 361.
- Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754–1760. doi:10.1001/archopht.124.12.1754.
- Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the global burden of disease 2013 study. Lancet Global Health. 2015;3(11):e712–23. doi:10.1016/S2214-109X(15)00069-8.
- Frick KD, Foster A. The magnitude and cost of global blindness: An increasing problem that can be alleviated. Am J Ophthalmol. 2003;135(4):471–476. doi:10.1016/S0002-9394(02)02110-4.
- Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol. 1998;46:169–172.
- Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol. 2006;90(3):272–275. doi:10.1136/bjo.2005.080986.
- Cruess AF, Zlateva G, Xu X, et al. Economic burden of bilateral neovascular age-related macular degeneration: Multi-country observational study. PharmacoEconomics. 2008;26(1):57–73. doi:10.2165/00019053-200826010-00006.
- PwC. The Value of Sight - the Fred Hollows Foundation. https://www.hollows.org/getattachment/au/Research/Investing-in-Vision/PwC-4-Value-of-Sight-Final-Report-2013.pdf.aspx. 2013.
- Eckert KA, Carter MJ, Lansingh VC, et al. A simple method for estimating the economic cost of productivity loss due to blindness and moderate to severe visual impairment. Ophthalmic Epidemiol. 2015;22(5):349–355. doi:10.3109/09286586.2015.1066394.
- Gordois A, Cutler H, Pezzullo L, et al. An estimation of the worldwide economic and health burden of visual impairment. Glob Public Health. 2012;7(5):465–481. doi:10.1080/17441692.2011.634815.
- Armstrong KL, Jovic M, Vo-Phuoc JL, Thorpe JG, Doolan BL. The global cost of eliminating avoidable blindness. Indian J Ophthalmol. 2012;60(5):475–480. doi:10.4103/0301-4738.100554.
- Fricke TR, Holden BA, Wilson DA, et al. Global cost of correcting vision impairment from uncorrected refractive error. Bull World Health Organ. 2012;90(10):728–738. doi:10.2471/BLT.00.000000.